Reaktion #157416

ord-1fa5ac3c992e41058c6b48415328a2c3

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Einengenthe reaction mixture was concentrated under reduced pressure
  2. 2
    Sonstigepurified by HPLC (5 to 50% MeCN/0.1% TFA in H2O/0.1% TFA gradient)
  3. 3
    workup.ADDITIONThe fractions containing the desired product
  4. 4
    Einengenwere concentrated under reduced pressure
  5. 5
    workup.DISSOLUTIONThe material was dissolved in MeOH (1 mL)
  6. 6
    workup.ADDITIONtreated with 4 M HCl in 1,4-dioxane (6 mL)
  7. 7
    EinengenThe mixture was concentrated under reduced pressure

Vorschrift

4 M HCl in 1,4-dioxane (6 mL, 24 mmol) was added to a solution of tert-butyl 4-(4-methoxyphenylcarbamoyl)-3-((pyridin-3-ylamino)methyl)piperazine-1-carboxylate TFA salt (81.7 mg, 0.147 mmol) in MeOH (1 mL). After 1 h, the reaction mixture was concentrated under reduced pressure and purified by HPLC (5 to 50% MeCN/0.1% TFA in H2O/0.1% TFA gradient). The fractions containing the desired product were concentrated under reduced pressure. The material was dissolved in MeOH (1 mL) and treated with 4 M HCl in 1,4-dioxane (6 mL). The mixture was concentrated under reduced pressure to give 49.9 mg (82%) of the title compound as a white solid. LC-MS: RT=1.95 min, [M+H]+=342.1.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08822472B2uspto-grants-2014_09